Target intelligence / Profile preview

Ribosomal protein L9 pseudogene 2 (RPL9P2)

Target
RPL9P2
Molecular classification
Other (Pseudogene)
01

Overview

RPL9P2 (Ribosomal protein L9 pseudogene 2) is a processed pseudogene corresponding to the functional ribosomal protein L9 gene (RPL9), a component of the 60S ribosomal subunit. Pseudogenes such as RPL9P2 are segments of DNA that are similar to known genes but typically contain defects (e.g., premature stop codons or frameshifts) that prevent them from coding for functional proteins. In the genome, many ribosomal protein genes have multiple processed pseudogenes dispersed throughout due to frequent retrotransposition events[1][5]. RPL9P2 is not transcribed into a functional protein and has no known biological activity, function, or disease association. Therefore, it is not considered a receptor, enzyme, or therapeutic target. RPL9P2 is formally annotated as a pseudogene in genomic databases, and there is no evidence it encodes an active protein or participates in any physiological or pathological processes[1][5]. Pseudogenes may occasionally be transcribed or have regulatory roles, but no such function is documented for RPL9P2 specifically[1][5]. Typical ribosomal proteins, such as RPL9, are important in the protein translation machinery; however, their pseudogenes are gene relics with no known translational role[4][7]. There are no known drugs, mechanisms of action, or safety concerns relevant to this pseudogene.

Other names
RPL9_10_151860S ribosomal protein L9 pseudogene 2RPL9P2[1]
02

Mechanism of action

Not applicable

03

Biological functions

None known (as a pseudogene, RPL9P2 does not encode an active or functional protein)
04

Disease associations

None directly (pseudogenes typically do not play direct disease-modifying roles; no direct clinical relevance is described)

Beyond the preview

Go deeper on Ribosomal protein L9 pseudogene 2 (RPL9P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L9 pseudogene 2 (RPL9P2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call